The Efficacy and Safety of Thunderbeat in Thyroid Surgery
Thunderbeat
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of this study is to compare the results of total thyroidectomy using the Thunderbeat device to that with the harmonic scalpel.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 20, 2014
CompletedFirst Posted
Study publicly available on registry
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedFebruary 15, 2016
February 1, 2016
1.1 years
November 20, 2014
February 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative complications including laryngeal nerve palsy, hypocalcemia, hemorrhage, hematoma, wound infection and skin burn
postoperatively (from the day of surgery until 3 months postoperatively)
Secondary Outcomes (2)
Hemostasis
intraoperatively (from skin incision to skin closure) & postoperatively (from skin closure until 2 day postoperatively)
Operative time
from skin incision to skin closure
Study Arms (2)
Thunderbeat (Group A)
ACTIVE COMPARATORPatients submitted to thyroidectomy with the use of the Thunderbeat device.
Harmonic (Group B)
ACTIVE COMPARATORPatients submitted to thyroidectomy with the use of the Harmonic scalpel device
Interventions
Eligibility Criteria
You may qualify if:
- thyroidectomy
- normal vocal cord
You may not qualify if:
- additional surgical procedures together with the total thyroidectomy (i.e., parathyroidectomy or cervical lymph node dissection)
- Thyroid cancer patients with lymph node metastasis
- pregnant women
- uncontrolled hypertension, DM, chronic kidney failure, coagulation disorders
- aspirin or anti-platelet agent in 7 days
- Graves' disease or Hashimoto thyroiditis
- history of radiation treatment in head and neck area
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- Olympus Korea Co., Ltd.collaborator
Study Sites (1)
Seoul National University Hospital
Seoul, 110-744, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Su-jin Kim, MD, PhD
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
November 20, 2014
First Posted
December 1, 2014
Study Start
November 1, 2014
Primary Completion
December 1, 2015
Study Completion
February 1, 2016
Last Updated
February 15, 2016
Record last verified: 2016-02